TITLE

Combating HIV in the first weeks of infection may be crucial

AUTHOR(S)
Delaney, Martin
PUB. DATE
June 1992
SOURCE
Advocate;6/2/92, Issue 604, p31
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Presents news items related to AIDS in the U.S. for the week of June 2, 1992. Discussion of the anti-AIDS drugs ddI and ddC at a Food and Drug Administration committee meeting; Comparison of AZT to the drugs; Reforms to achieve faster drug-approval procedures; Planned national march against AIDS; Early treatment of HIV infections.
ACCESSION #
9673117

 

Related Articles

  • Is There A Cure For AIDS?  // Public Health Reports;May/Jun88, Vol. 103 Issue 3, p333 

    The article reveals that presently. there is no cure for AIDS. Medicines such as AZT have prolonged the lives of some patients with AIDS. There is no vaccine to prevent uninfected people from getting AIDS. The article reports that it may take years for an effective, safe vaccine to be found. It...

  • MEDICAL BRIEFS. Cohan, Gary R. // Advocate;9/7/93, Issue 637, p39 

    Presents news concerning AIDS as of September 1993. Ban on the sale of HIV tests in France; Role of AZT in HIV infection; Analysis of AIDS research in the U.S.

  • Impact of Indinavir on the Quality of Life in Patients with Advanced HIV Infection Treated with Zidovudine and Lamivudine. Coplan, Paul M.; Cook, John R.; Carides, George W.; Heyse, Joseph F.; Wu, Albert W.; Hammer, Scott M.; Nguyen, Bach-Yen; Meibohm, Anne R.; DiNubile, Mark J. // Clinical Infectious Diseases;8/1/2004, Vol. 39 Issue 3, p426 

    Objective. in AIDS Clinical Trial Group (ACTG) study 320, triple-combination antiretroviral therapy including indinavir significantly slowed progression to acquired immunodeficiency syndrome or death, compared with treatment with dual nucleoside reverse-transcriptase inhibitors (NRTIs) alone, in...

  • THE CURE THAT FAILED. Bethell, Tom // National Review;5/10/1993, Vol. 45 Issue 9, p33 

    The article questions whether AIDS lobbyists knew what they were doing when it pressed the U.S. government to approve the AZT drug. The drug was designed in 1964 as cancer treatment. Because of its side-effects, it was never approved. The rise in the demand for AIDS treatment led to its...

  • Combination Therapy for HIV Infection: Getting Closer. Fanci, Anthony S. // Annals of Internal Medicine;1/1/92, Vol. 116 Issue 1, p85 

    Editorial. Comments on issues regarding combination therapy with antiretroviral agents for HIV infection in the U.S. as of January 1992. Observations on research in combination therapy; Views on the use of zidovudine for HIV treatment; Insights on the role of surrogate markers.

  • An antiviral breakthrough. Cohan, Gary R. // Advocate;2/7/95, Issue 674, p43 

    Reports on using AZT with a new drug called 3TC as HIV treatment. Problems with the medications; Benefits and effectiveness of the drug combination.

  • Study shows Retrovir can prevent mother-to-infant HIV transmission.  // New York Amsterdam News;11/12/94, Vol. 85 Issue 46, p14 

    Reports on the preliminary results of a study on the treatment of HIV-infected women and their newborns with Retrovir. Reduction of the risk of maternal-to-fetal transmission of the virus; Food and Drug administration's approval of the drug for the indication; Study protocol.

  • Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998. Vuthipongse, P.; Bhadrakom, C.; Chaisilwattana, P.; Roongpisuthipong, A.; Chalermchokcharoenkit, A.; Chearskul, S.; Wanprapa, N.; Chokephaibulkit, K.; Tuchinda, M.; Wasi, C.; Chuachoowong, R.; Siriwasin, W.; Chinayon, P.; Asavapiriyanont, S.; Chotpitayasunondh, T.; Waranawat, N.; Sangtaweesin, V.; Horpaopan, S. // JAMA: Journal of the American Medical Association;4/8/98, Vol. 279 Issue 14, p1061 

    Examines the use of zidovudine (ZDV) to prevent perinatal infection with HIV. Testing of drug in the United States and Thailand; Effects of short-term antenatal regimen of ZDV; Methods used in research; Data collected; Estimated HIV transmission risk; Importance of study; Shorter regimen...

  • Medical microbiology.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS56 

    Presents an abstract of the research manuscript `Risk reduction of mother-to-child HIV transmission by antiretroviral therapy in a clinical setting,' by N. Lapointe et al. Zidovudine treatment.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics